BOSTON--(BUSINESS WIRE)--Macular Therapeutics, Inc., (MCT) a private biotechnology company targeting neuromodulation and molecular-guided tissue remodeling to stabilize cellular barriers and tissue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback